Title |
Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
|
---|---|
Published in |
The Journal of Headache and Pain, October 2017
|
DOI | 10.1186/s10194-017-0815-1 |
Pubmed ID | |
Authors |
Simona Sacco, Gabriele S. Merki-Feld, Karen Lehrmann Ægidius, Johannes Bitzer, Marianne Canonico, Tobias Kurth, Christian Lampl, Øjvind Lidegaard, E. Anne MacGregor, Antoinette MaassenVanDenBrink, Dimos-Dimitrios Mitsikostas, Rossella Elena Nappi, George Ntaios, Per Morten Sandset, Paolo Martelletti, on behalf of the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC) |
Abstract |
Several data indicate that migraine, especially migraine with aura, is associated with an increased risk of ischemic stroke and other vascular events. Of concern is whether the risk of ischemic stroke in migraineurs is magnified by the use of hormonal contraceptives. As migraine prevalence is high in women of reproductive age, it is common to face the issue of migraine and hormonal contraceptive use in clinical practice. In this document, we systematically reviewed data about the association between migraine, ischemic stroke and hormonal contraceptive use. Thereafter a consensus procedure among international experts was done to develop statements to support clinical decision making, in terms of cardiovascular safety, for prescription of hormonal contraceptives to women with migraine. Overall, quality of current evidence regarding the risk of ischemic stroke in migraineurs associated with the use of hormonal contraceptives is low. Available data suggest that combined hormonal contraceptive may further increase the risk of ischemic stroke in those who have migraine, specifically migraine with aura. Thus, our current statements privilege safety and provide several suggestions to try to avoid possible risks. As the quality of available data is poor further research is needed on this topic to increase safe use of hormonal contraceptives in women with migraine. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 4 | 14% |
United Kingdom | 3 | 11% |
Italy | 2 | 7% |
Chile | 2 | 7% |
Latvia | 1 | 4% |
United States | 1 | 4% |
Canada | 1 | 4% |
Nepal | 1 | 4% |
Brazil | 1 | 4% |
Other | 0 | 0% |
Unknown | 12 | 43% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 20 | 71% |
Science communicators (journalists, bloggers, editors) | 3 | 11% |
Practitioners (doctors, other healthcare professionals) | 3 | 11% |
Scientists | 2 | 7% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 197 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 24 | 12% |
Researcher | 18 | 9% |
Student > Master | 18 | 9% |
Other | 14 | 7% |
Student > Ph. D. Student | 14 | 7% |
Other | 36 | 18% |
Unknown | 73 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 66 | 34% |
Nursing and Health Professions | 13 | 7% |
Neuroscience | 8 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 4% |
Biochemistry, Genetics and Molecular Biology | 7 | 4% |
Other | 12 | 6% |
Unknown | 83 | 42% |